Does THROMBOMODULIN ALFA Cause Disseminated intravascular coagulation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Disseminated intravascular coagulation have been filed in association with THROMBOMODULIN ALFA. This represents 12.5% of all adverse event reports for THROMBOMODULIN ALFA.
9
Reports of Disseminated intravascular coagulation with THROMBOMODULIN ALFA
12.5%
of all THROMBOMODULIN ALFA reports
4
Deaths
5
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From THROMBOMODULIN ALFA?
Of the 9 reports, 4 (44.4%) resulted in death, 5 (55.6%) required hospitalization, and 4 (44.4%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THROMBOMODULIN ALFA. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does THROMBOMODULIN ALFA Cause?
Drug ineffective (15)
Off label use (11)
Thrombotic microangiopathy (11)
Blood alkaline phosphatase increased (7)
Blood creatinine increased (7)
Blood urea increased (7)
Cardiac failure acute (7)
Gamma-glutamyltransferase increased (7)
Weight increased (7)
Diarrhoea (6)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)